ArticleNAR genomics and bioinformatics2025
Determinant-based grouping of SNPs and its application for detecting disease-associated genomic loci.
Article in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Groups of single nucleotide polymorphisms (SNPs) are more effective than individual SNPs in identifying genetic loci associated with diseases. However, an optimal method for grouping SNPs remains an open question. Here, we introduce a novel approach for SNP grouping, leveraging the determinant of linkage disequilibrium (LD) matrices as a comprehensive metric of multicollinearity. This method builds on the established use of determinants in regression analysis as an aggregate measure of variable interdependence. We proposed that SNPs be grouped by evaluating the determinant of their LD matrices, with the approach validated using both synthetic genotype-phenotype data and real-world data from genome-wide association studies (GWAS) of ischemic stroke. Application of this method identified two previously known and five novel candidate genes associated with the onset of disease. Additionally, we developed a straightforward procedure to estimate a critical parameter for the model: the minimal determinant value for an LD matrix to be considered singular. In summary, the determinant of the LD matrix serves as a robust integrative measure for assessing SNP group quality. This metric underpins a bioinformatics workflow capable of identifying genomic loci associated with disease onset, offering a valuable tool for advancing genetic association studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.